117 related articles for article (PubMed ID: 10230503)
1. Anti-ulcer activity of newly synthesized acylquinoline derivatives.
Cheon HG; Kim HJ; Mo HK; Shin E; Lee Y
Arch Pharm Res; 1999 Apr; 22(2):137-42. PubMed ID: 10230503
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on the new quinoline derivative 1-(2-methylphenyl)-4-[(3-hydroxypropyl) amino]-6-trifluoromethoxy-2,3-dihydropyrrolo[3,2-c] quinoline with potent anti-ulcer effect.
Cheon HG; Kim HJ; Kim SS; Choi JK; Kong JY
Arzneimittelforschung; 1998 Dec; 48(12):1168-71. PubMed ID: 9893932
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
Cheon HG; Lee SS; Lim H; Lee DH
Eur J Pharmacol; 2001 Jan; 411(1-2):187-192. PubMed ID: 11137875
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of the gastric H(+)/K(+) ATPase inhibitor, AU-461.
Cheon HG; Kim HJ; Mo HK; Lee BH; Choi J
Pharmacology; 2000 Apr; 60(3):161-8. PubMed ID: 10754453
[TBL] [Abstract][Full Text] [Related]
6. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.
Yum EK; Kang SK; Kim SS; Choi JK; Cheon HG
Bioorg Med Chem Lett; 1999 Oct; 9(19):2819-22. PubMed ID: 10522698
[TBL] [Abstract][Full Text] [Related]
8. The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol e.
Chung YK; Chang MS; Kim KB; Sohn SK; Woo TW; Lee SB; Choi WS
Can J Physiol Pharmacol; 1998 Sep; 76(9):921-9. PubMed ID: 10066143
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
[TBL] [Abstract][Full Text] [Related]
11. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
12. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
[TBL] [Abstract][Full Text] [Related]
13. Gastroprotective and anti-secretory mechanisms of 2-phenylquinoline, an alkaloid isolated from Galipea longiflora.
Breviglieri E; Mota da Silva L; Boeing T; Somensi LB; Cury BJ; Gimenez A; Cechinel Filho V; de Andrade SF
Phytomedicine; 2017 Feb; 25():61-70. PubMed ID: 28190472
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5).
Sohn SK; Chang MS; Chung YK; Kim KB; Wook TW; Kim SG; Choi WS
Arch Pharm Res; 1998 Jun; 21(3):241-7. PubMed ID: 9875438
[TBL] [Abstract][Full Text] [Related]
15. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
16. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
17. Gastroprotective effect of Neem (Azadirachta indica) bark extract: possible involvement of H(+)-K(+)-ATPase inhibition and scavenging of hydroxyl radical.
Bandyopadhyay U; Biswas K; Chatterjee R; Bandyopadhyay D; Chattopadhyay I; Ganguly CK; Chakraborty T; Bhattacharya K; Banerjee RK
Life Sci; 2002 Nov; 71(24):2845-65. PubMed ID: 12377267
[TBL] [Abstract][Full Text] [Related]
18. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the gastric H+,K+ -ATPase by plectrinone A, a diterpenoid isolated from Plectranthus barbatus Andrews.
Schultz C; Bossolani MP; Torres LM; Lima-Landman MT; Lapa AJ; Souccar C
J Ethnopharmacol; 2007 Apr; 111(1):1-7. PubMed ID: 17166678
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and rats.
Sohn SK; Chang MS; Choi WS; Chung YK; Kim KB; Woo TW; Lee SB; Park CJ
J Pharm Pharmacol; 1999 Dec; 51(12):1359-65. PubMed ID: 10678489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]